Guardant Health Stock Performance
| GH Stock | USD 16.07 0.60 3.60% |
The company retains a Market Volatility (i.e., Beta) of 2.03, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Guardant Health will likely underperform. Guardant Health has an expected return of -0.44%. Please make sure to check out Guardant Health maximum drawdown, rate of daily change, and the relationship between the jensen alpha and kurtosis , to decide if Guardant Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Guardant Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in May 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return 1.71 | Five Day Return (9.50) | Year To Date Return (37.12) | Ten Year Return (48.23) | All Time Return (48.23) |
1 | Guardant Health Inc Reports 25 percent Revenue Growth in Full Year 2023 | 02/22/2024 |
2 | Guardant Health, Inc. Shares Sold by Trexquant Investment LP | 02/28/2024 |
3 | Guardant Health, Inc. Stock Holdings Boosted by Seven Eight Capital LP | 03/06/2024 |
4 | California State Teachers Retirement System Has 3.66 Million Stock Holdings in Guardant Health, Inc. - Defense World | 03/11/2024 |
5 | Disposition of 1233 shares by Michael Bell of Guardant Health subject to Rule 16b-3 | 03/15/2024 |
6 | EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices | 03/18/2024 |
7 | GUARDANT HEALTH INC. Revenue Breakdown SWB5GH TradingView - TradingView | 03/21/2024 |
8 | Acquisition by Merrill Amelia of 158 shares of Guardant Health subject to Rule 16b-3 | 03/25/2024 |
9 | The next Nvidia 3 stocks poised for massive growth in 2024 | 04/03/2024 |
10 | Disposition of tradable shares by Joyce Meghan V. of Guardant Health subject to Rule 16b-3 | 04/04/2024 |
11 | Guardant Health Stock Price Up 4.9 percent - MarketBeat | 04/08/2024 |
12 | Disposition of tradable shares by Potter Myrtle S of Guardant Health subject to Rule 16b-3 | 04/15/2024 |
13 | Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024 | 04/18/2024 |
| Begin Period Cash Flow | 141.6 M |
Guardant |
Guardant Health Relative Risk vs. Return Landscape
If you would invest 2,322 in Guardant Health on January 20, 2024 and sell it today you would lose (655.00) from holding Guardant Health or give up 28.21% of portfolio value over 90 days. Guardant Health is generating negative expected returns and assumes 4.054% volatility on return distribution over the 90 days horizon. Put differently, 35% of stocks are less risky than Guardant on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Guardant Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardant Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Guardant Health, and traders can use it to determine the average amount a Guardant Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1095
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GH |
Estimated Market Risk
| 4.05 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.44 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Guardant Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Guardant Health by adding Guardant Health to a well-diversified portfolio.
Guardant Health Fundamentals Growth
Guardant Stock prices reflect investors' perceptions of the future prospects and financial health of Guardant Health, and Guardant Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guardant Stock performance.
| Return On Equity | -4.38 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.85) % | ||||
| Operating Margin | (0.73) % | ||||
| Current Valuation | 2.21 B | ||||
| Shares Outstanding | 121.71 M | ||||
| Price To Earning | (12.01) X | ||||
| Price To Book | 14.01 X | ||||
| Price To Sales | 3.94 X | ||||
| Revenue | 563.95 M | ||||
| Gross Profit | 293.21 M | ||||
| EBITDA | (519.63 M) | ||||
| Net Income | (479.45 M) | ||||
| Cash And Equivalents | 853.69 M | ||||
| Cash Per Share | 8.35 X | ||||
| Total Debt | 1.35 B | ||||
| Debt To Equity | 4.32 % | ||||
| Current Ratio | 6.18 X | ||||
| Book Value Per Share | 1.30 X | ||||
| Cash Flow From Operations | (324.98 M) | ||||
| Earnings Per Share | (4.28) X | ||||
| Market Capitalization | 2.03 B | ||||
| Total Asset | 1.79 B | ||||
| Retained Earnings | (2.14 B) | ||||
| Working Capital | 1.14 B | ||||
| Current Asset | 219.68 M | ||||
| Current Liabilities | 24.24 M | ||||
About Guardant Health Performance
To evaluate Guardant Health Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Guardant Health generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Guardant Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Guardant Health market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Guardant's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 99.59 | 68.61 | |
| Return On Tangible Assets | (0.27) | (0.28) | |
| Return On Capital Employed | (0.36) | (0.37) | |
| Return On Assets | (0.27) | (0.28) | |
| Return On Equity | (3.02) | (3.17) |
Things to note about Guardant Health performance evaluation
Checking the ongoing alerts about Guardant Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Guardant Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Guardant Health generated a negative expected return over the last 90 days | |
| Guardant Health has high historical volatility and very poor performance | |
| Guardant Health has high likelihood to experience some financial distress in the next 2 years | |
| The company generated the yearly revenue of 563.95 M. Annual Net Loss to common stockholders was (479.45 M) with gross profit of 293.21 M. | |
| Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35. | |
| Guardant Health has a poor financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024 |
- Analyzing Guardant Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guardant Health's stock is overvalued or undervalued compared to its peers.
- Examining Guardant Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Guardant Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guardant Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Guardant Health's stock. These opinions can provide insight into Guardant Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.